University at Buffalo - The State University of New York
Skip to Content
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer. - PubMed - NCBI
Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Breast Cancer. 2003 Feb;3(6):421-2.

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.

Author information

1
Indiana Cancer Pavillion, Indianapolis, IN 46202, USA. kathmill@iupui.edu
PMID:
12636887
DOI:
10.3816/CBC.2003.n.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center